BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6321606)

  • 1. Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids.
    Hardy AM; Wajszczuk CP; Suffredini AF; Hakala TR; Ho M
    J Infect Dis; 1984 Feb; 149(2):143-7. PubMed ID: 6321606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pneumocystis carinii pneumonia in renal transplant recipients treated with cyclosporin].
    Kim CJ; Pak K; Wakabayashi Y; Ishida A; Arai Y; Konishi T; Kounami T; Tomoyoshi T; Sako H; Okino K
    Hinyokika Kiyo; 1989 Apr; 35(4):653-9. PubMed ID: 2544088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. Implication of folinic acid.
    Nunn PP; Allistone JC
    Chest; 1984 Jul; 86(1):149-50. PubMed ID: 6610537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does cyclosporin A adversely affect Pneumocystis carinii infection?
    McGonigle RJ; Beaman M; Stone J; Young J; Michael J; Adu D
    Postgrad Med J; 1988 Sep; 64(755):659-62. PubMed ID: 3266947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine therapy and refractory Pneumocystis carinii pneumonia. A potential association.
    Franson TR; Kauffman HM; Adams MB; Lemann J; Cabrera E; Hanacik L
    Arch Surg; 1987 Sep; 122(9):1034-5. PubMed ID: 3304199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
    Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
    Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors in an outbreak of Pneumocystis carinii in a transplant unit.
    Santiago-Delpín EA; Mora E; González ZA; Morales-Otero LA; Bermudez R
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):462-5. PubMed ID: 2831643
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of trimethoprim-sulfamethoxazole in the therapy of recurrent Pneumocystis carinii pneumonia.
    Mitsuyasu RT; Corwin HL; Harris AA; Trenholme GM; Levi S; Karkusis PH
    Am Rev Respir Dis; 1982 Jun; 125(6):762-5. PubMed ID: 6979960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
    Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
    Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis.
    de Boer MG; Kroon FP; le Cessie S; de Fijter JW; van Dissel JT
    Transpl Infect Dis; 2011 Dec; 13(6):559-69. PubMed ID: 21689251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis.
    Anand S; Samaniego M; Kaul DR
    Transpl Infect Dis; 2011 Dec; 13(6):570-4. PubMed ID: 22093215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumocystis carinii pneumonia following heart transplantation.
    Schäfers HJ; Cremer J; Wahlers T; Holle W; Fieguth HG; Herrmann G; Haverich A
    Eur J Cardiothorac Surg; 1987; 1(1):49-52. PubMed ID: 3273214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Changing Landscape of Pneumocystis Jiroveci Infection in Kidney Transplant Recipients: Single-Center Experience of Late-Onset Pneumocystis Pneumonia.
    Marinaki S; Vallianou K; Melexopoulou C; Lionaki S; Darema M; Lambrou P; Boletis I
    Transplant Proc; 2021 Jun; 53(5):1576-1582. PubMed ID: 33962778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis jirovecii pneumonia in kidney transplantation.
    Goto N; Oka S
    Transpl Infect Dis; 2011 Dec; 13(6):551-8. PubMed ID: 22093172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience.
    Borstnar S; Lindic J; Tomazic J; Kandus A; Pikelj A; Prah J; Skvarc M; Godnov U; Kovac D
    Transplant Proc; 2013 May; 45(4):1614-7. PubMed ID: 23726632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim with sulfamethoxazole for treatment of infection with Pneumocystis carinii in renal insufficiency.
    Bourgault AM; Van Scoy RE; Brewer NS; Rosenow EC
    Chest; 1978 Jul; 74(1):91-2. PubMed ID: 307483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation.
    Gabardi S; Millen P; Hurwitz S; Martin S; Roberts K; Chandraker A
    Clin Transplant; 2012; 26(3):E184-90. PubMed ID: 22487221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
    Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
    Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-trimoxazole treatment of two fatal cases of Pneumocystis carinii pneumonia--changes in protozoan morphology and treatment method.
    Mori T; Matsumura M; Takahashi M; Isonuma H; Hibiya I; Yasuma M; Hamamoto T; Ikemoto H; Okada M
    Kansenshogaku Zasshi; 1987 Feb; 61(2):118-25. PubMed ID: 3112273
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study.
    Radisic M; Lattes R; Chapman JF; del Carmen Rial M; Guardia O; Seu F; Gutierrez P; Goldberg J; Casadei DH
    Transpl Infect Dis; 2003 Jun; 5(2):84-93. PubMed ID: 12974789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.